vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Sila Realty Trust, Inc. (SILA). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $50.1M, roughly 1.7× Sila Realty Trust, Inc.). Sila Realty Trust, Inc. runs the higher net margin — 10.0% vs 6.8%, a 3.2% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 7.6%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Sila Realty Trust, Inc. is a U.S.-based real estate investment trust that owns, operates, and acquires high-quality income-generating commercial properties. Its core portfolio covers industrial logistics facilities, office assets and mixed-use properties, serving tenants across logistics, corporate and retail segments to deliver stable long-term returns.
BLLN vs SILA — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $50.1M |
| Net Profit | $5.7M | $5.0M |
| Gross Margin | 69.9% | 88.9% |
| Operating Margin | 11.5% | — |
| Net Margin | 6.8% | 10.0% |
| Revenue YoY | 117.4% | 7.6% |
| Net Profit YoY | 138.3% | -54.9% |
| EPS (diluted) | $0.10 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $50.1M | ||
| Q3 25 | $83.5M | $49.8M | ||
| Q2 25 | — | $48.7M | ||
| Q1 25 | — | $48.3M | ||
| Q4 24 | — | $46.5M | ||
| Q3 24 | $38.4M | $46.1M | ||
| Q2 24 | — | $43.6M | ||
| Q1 24 | — | $50.6M |
| Q4 25 | — | $5.0M | ||
| Q3 25 | $5.7M | $11.6M | ||
| Q2 25 | — | $8.6M | ||
| Q1 25 | — | $7.9M | ||
| Q4 24 | — | $11.1M | ||
| Q3 24 | $-14.9M | $11.9M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | — | 88.9% | ||
| Q3 25 | 69.9% | 88.1% | ||
| Q2 25 | — | 87.7% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.3% | ||
| Q3 24 | 52.6% | 87.4% | ||
| Q2 24 | — | 86.6% | ||
| Q1 24 | — | 89.0% |
| Q4 25 | — | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -32.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 10.0% | ||
| Q3 25 | 6.8% | 23.3% | ||
| Q2 25 | — | 17.6% | ||
| Q1 25 | — | 16.4% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | -38.8% | 25.9% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | 29.6% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | $0.10 | $0.21 | ||
| Q2 25 | — | $0.15 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.20 | ||
| Q3 24 | $-1.47 | $0.21 | ||
| Q2 24 | — | $0.08 | ||
| Q1 24 | — | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $32.3M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $1.3B |
| Total Assets | $327.5M | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $32.3M | ||
| Q3 25 | $195.2M | $27.7M | ||
| Q2 25 | — | $24.8M | ||
| Q1 25 | — | $30.5M | ||
| Q4 24 | — | $39.8M | ||
| Q3 24 | — | $28.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $90.2M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.3B | ||
| Q3 25 | $-239.5M | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $-242.9M | $1.4B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | $2.1B | ||
| Q3 25 | $327.5M | $2.1B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $119.1M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | 23.76× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $119.1M | ||
| Q3 25 | $13.8M | $30.0M | ||
| Q2 25 | — | $31.9M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $132.8M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | — | $36.6M |
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 23.76× | ||
| Q3 25 | 2.42× | 2.59× | ||
| Q2 25 | — | 3.71× | ||
| Q1 25 | — | 3.06× | ||
| Q4 24 | — | 11.95× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 6.84× | ||
| Q1 24 | — | 2.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
SILA
Segment breakdown not available.
